FKBP3 and cancer: Th1 type response contributed to antitumor response in cancer development and associated with improved overall survival of cancer patients.[35] All these results demonstrated that overexpression of FKBP3 promoted LUAD progression partly by inhibiting the Th1 type response and promoting Th2-type immune response.